Oncolytic virotherapy for multiple myeloma using a tumour-specific double-deleted vaccinia virus
Tóm tắt
Từ khóa
Tài liệu tham khảo
Coffey MC, Strong JE, Forsyth PA, Lee PW . Reovirus therapy of tumors with activated Ras pathway. Science 1998; 282: 1332–1334.
Stojdl DF, Lichty B, Knowles S, Marius R, Atkins H, Sonenberg N et al. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nature Med 2000; 6: 821–825.
Martuza RL, Malick A, Markert JM, Ruffner KL, Coen DM . Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 1991; 252: 854–856.
McCart JA, Ward JM, Lee J, Hu Y, Alexander HR, Libutti SK et al. Systemic cancer therapy with a tumor selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes. Cancer Res 2001; 61: 8751–8757.
Jounaidi Y, Doloff JC, Waxman DJ . Conditionally replicating adenoviruses for cancer treatment. Curr Cancer Drug Targets 2007; 7: 285–301.
Peng KW, Ahmann GJ, Pham L, Greipp PR, Russell SJ . Systemic therapy of myeloma xenografts by an attenuated measles virus. Blood 2001; 98: 2002–2007.
Peng KW, Donovan KA, Schneider U, Cattaneo R, Lust JA, Russell SJ . Oncolytic measles virus displaying a single chain antibody against CD38, a myeloma cell marker. Blood 2001; 101: 2557–2562.
Lichty BD, Stojdl DF, Taylor RA, Miller L, Frenkel I, Atkins H et al. Vesicular stomatitis virus: a potential therapeutic virus for the treatment of hematological malignancy. Hum Gene Ther 2004; 15: 821–831.
Au GG, Lincz LF, Enno A, Shafren DR . Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma. Br J Haematol 2007; 137: 133–141.
Mitsiades CS, Mitsiades NS, Bronson RT, Chauhan D, Munshi N, Treon SP et al. Fluorescence imaging of multiple myeloma cells in a clinically relevant SCID/NOD in vivo model: biologic and clinical implications. Cancer Res 2003; 63: 6689–6696.